Skip to main content
SpringerLink
Log in

Towards intra-articular therapies for more than just symptom management in osteoarthritis

  • Practical Issues and Updates
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

Abstract

Osteoarthritis is a chronic condition that causes pain and loss of joint function. While currently recommended intra-articular therapies (e.g. corticosteroids and hyaluronic acid) can alleviate some of the symptoms of osteoarthritis, they are currently unable to alter the course of disease progression, and the duration of symptom relief is generally short-term. New therapies are under evaluation for treatment of osteoarthritis; these aim to reverse the pathological structural changes associated with the disease and provide longer-lasting pain relief. This article summarises recent guideline recommendations for intra-articular therapies and highlights some of the new therapies currently in clinical evaluation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Allen KD, Thoma LM, Golightly YM. Epidemiology of osteoarthritis. Osteoarthr Cartil. 2022;30(2):184–95.

    Article  CAS  Google Scholar 

  2. Oo WM, Hunter DJ. Repurposed and investigational disease-modifying drugs in osteoarthritis (DMOADs). Ther Adv Musculoskelet Dis. 2022;14:1–29.

    Article  Google Scholar 

  3. Assi R, Quintiens J, Monteagudo S, et al. Innovation in targeted intra-articular therapies for osteoarthritis. Drugs. 2023;83(8):649–63.

    Article  PubMed  Google Scholar 

  4. Kolasinski SL, Neogi T, Hochberg MC, et al. 2019 American college of rheumatology/arthritis foundation guideline for the management of osteoarthritis of the hand, hip, and knee. Arthritis Rheumatol. 2020;72(2):220–33.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Bruyere O, Honvo G, Veronese N, et al. An updated algorithm recommendation for the management of knee osteoarthritis from the european society for clinical and economic aspects of osteoporosis, osteoarthritis and musculoskeletal diseases (ESCEO). Semin Arthritis Rheum. 2019;49(3):337–50.

    Article  PubMed  Google Scholar 

  6. Bannuru RR, Osani MC, Vaysbrot EE, et al. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthr Cartil. 2019;27(11):1578–89.

    Article  CAS  Google Scholar 

  7. Mobasheri A, Kapoor M, Ali SA, et al. The future of deep phenotyping in osteoarthritis: how can high throughput omics technologies advance our understanding of the cellular and molecular taxonomy of the disease? Osteoarthr Cartil Open. 2021;3(4): 100144.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Dieppe PA, Sathapatayavongs B, Jones HE, et al. Intra-articular steroids in osteoarthritis. Rheumatol Rehabil. 1980;19(4):212–7.

    Article  CAS  PubMed  Google Scholar 

  9. Rydell N, Balazs EA. Effect of intra-articular injection of hyaluronic acid on the clinical symptoms of osteoarthritis and on granulation tissue formation. Clin Orthop Relat Res. 1971;80:25–32.

    Article  CAS  PubMed  Google Scholar 

  10. Choueiri M, Chevalier X, Eymard F. Intraarticular corticosteroids for hip osteoarthritis: a review. Cartilage. 2021;13(1):122S-131S.

    Article  PubMed  Google Scholar 

  11. Bedard NA, DeMik DE, Glass NA, et al. Impact of clinical practice guidelines on use of intra-articular hyaluronic acid and corticosteroid injections for knee osteoarthritis. J Bone Joint Surg Am. 2018;100(10):827–34.

    Article  PubMed  Google Scholar 

  12. Gato-Calvo L, Magalhaes J, Ruiz-Romero C, et al. Platelet-rich plasma in osteoarthritis treatment: review of current evidence. Ther Adv Chronic Dis. 2019;10:2040622319825567.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Arroll B, Goodyear-Smith F. Corticosteroid injections for osteoarthritis of the knee: meta-analysis. BMJ. 2004;328(7444):869.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Saltychev M, Mattie R, McCormick Z, et al. The magnitude and duration of the effect of intra-articular corticosteroid injections on pain severity in knee osteoarthritis: a systematic review and meta-analysis. Am J Phys Med Rehabil. 2020;99(7):617–25.

    Article  PubMed  Google Scholar 

  15. Altman R, Hackel J, Niazi F, et al. Efficacy and safety of repeated courses of hyaluronic acid injections for knee osteoarthritis: a systematic review. Semin Arthritis Rheum. 2018;48(2):168–75.

    Article  CAS  PubMed  Google Scholar 

  16. Chavda S, Rabbani SA, Wadhwa T. Role and effectiveness of intra-articular injection of hyaluronic acid in the treatment of knee osteoarthritis: a systematic review. Cureus. 2022;14(4):e24503.

    PubMed  PubMed Central  Google Scholar 

  17. Rutjes AW, Juni P, da Costa BR, et al. Viscosupplementation for osteoarthritis of the knee: a systematic review and meta-analysis. Ann Intern Med. 2012;157(3):180–91.

    Article  PubMed  Google Scholar 

  18. Altman RD, Ike RW, Hamburger MI, et al. Missing the mark? American college of rheumatology 2019 guidelines for intraarticular hyaluronic acid injection and osteoarthritis knee pain. J Rheumatol. 2022;49(8):958–60.

    Article  PubMed  Google Scholar 

  19. Estee MM, Cicuttini FM, Page MJ, et al. Efficacy of corticosteroids for hand osteoarthritis - a systematic review and meta-analysis of randomized controlled trials. BMC Musculoskelet Disord. 2022;23(1):665.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Miller LE, Fredericson M, Altman RD. Hyaluronic acid injections or oral nonsteroidal anti-inflammatory drugs for knee osteoarthritis: systematic review and meta-analysis of randomized trials. Orthop J Sports Med. 2020;8(1):2325967119897909.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Yu SP, van Middelkoop M, Deveza LA, et al. Predictors of placebo response to local (intra-articular) therapy in osteoarthritis—an individual participant data meta-analysis. Arthritis Care Res. 2023. https://doi.org/10.1002/acr.25212.

    Article  Google Scholar 

  22. Hunter DJ, Chang CC, Wei JC, et al. TLC599 in patients with osteoarthritis of the knee: a phase IIa, randomized, placebo-controlled, dose-finding study. Arthritis Res Ther. 2022;24(1):52.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Malone A, Price J, Price N, et al. Safety and pharmacokinetics of EP-104IAR (sustained-release fluticasone propionate) in knee osteoarthritis: a randomized, double-blind, placebo-controlled phase 1 trial. Osteoarthr Cartil Open. 2021;3(4): 100213.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Nishida Y, Kano K, Nobuoka Y, et al. Efficacy and safety of diclofenac-hyaluronate conjugate (diclofenac etalhyaluronate) for knee osteoarthritis: a randomized phase III trial in Japan. Arthritis Rheumatol. 2021;73(9):1646–55.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Kim MK, Ha CW, In Y, et al. A multicenter, double-blind, phase III clinical trial to evaluate the efficacy and safety of a cell and gene therapy in knee osteoarthritis patients. Hum Gene Ther Clin Dev. 2018;29(1):48–59.

    Article  CAS  PubMed  Google Scholar 

  26. Thewlis D, Collins S, Huston M, et al. Functional improvements in knee kinematics during walking gait over six months following treatment with XT-150: pooled results from two clinical trials [abstract no. 60]. Osteoarthr Cartil. 2023;31(1):S121–2.

    Article  Google Scholar 

  27. Hochberg MC, Guermazi A, Guehring H, et al. Effect of intra-articular sprifermin vs placebo on femorotibial joint cartilage thickness in patients with osteoarthritis: the FORWARD randomized clinical trial. JAMA. 2019;322(14):1360–70.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Yazici Y, McAlindon TE, Gibofsky A, et al. Lorecivivint, a novel intraarticular CDC-like kinase 2 and dual-specificity tyrosine phosphorylation-regulated kinase 1A inhibitor and wnt pathway modulator for the treatment of knee osteoarthritis: a phase II randomized trial. Arthritis Rheumatol. 2020;72(10):1694–706.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Yazici Y, McAlindon TE, Gibofsky A, et al. A phase 2b randomized trial of lorecivivint, a novel intra-articular CLK2/DYRK1A inhibitor and wnt pathway modulator for knee osteoarthritis. Osteoarthr Cartil. 2021;29(5):654–66.

    Article  CAS  Google Scholar 

  30. Saxer F, Laurent D, Scotti C, et al. Cartilage regeneration after treatment with LNA043, a novel disease-modifying osteoarthritis drug candidate: results from an imaging-based proof-of-concept trial in patients with focal articular cartilage lesions in the knee [abstract no. V-272]. Osteoarthr Cartil. 2022;30(1):206–7.

    Article  Google Scholar 

  31. McGuire D, Bowes M, Brett A, et al. Study TPX-100-5: intra-articular TPX-100 significantly delays pathological bone shape change and stabilizes cartilage in moderate to severe bilateral knee OA. Arthritis Res Ther. 2021;23(1):242.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Stevens RM, Ervin J, Nezzer J, et al. Randomized, double-blind, placebo-controlled trial of intraarticular trans-capsaicin for pain associated with osteoarthritis of the knee. Arthritis Rheumatol. 2019;71(9):1524–33.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Springer Nature, Private Bag 65901, Mairangi Bay, Auckland, 0754, New Zealand

    Simon Fung

Authors
  1. Simon Fung
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Simon Fung.

Ethics declarations

Funding

The preparation of this review was not supported by any external funding.

Authorship and conflict of interest

S. Fung is a salaried employee of Adis International Ltd/Springer Nature and declares no relevant conflicts of interest. All authors contributed to this article and are responsible for its content.

Ethics approval, Consent to participate, Consent for publication, Availability of data and material, Code availability

Not applicable.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fung, S. Towards intra-articular therapies for more than just symptom management in osteoarthritis. Drugs Ther Perspect 39, 382–387 (2023). https://doi.org/10.1007/s40267-023-01029-6

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40267-023-01029-6

Search

Navigation